Advantages: Minimizes overlapping GLP-1 receptor activation Reduces nausea risk during first tirzepatide dose Allows clear attribution of side effects to the new medication Disadvantages: 7 to 10 day gap in appetite suppression Some patients report increased hunger and modest weight regain (1 to 3 pounds) during washout Psychological difficulty for patients who rely on medication for appetite control Clinical data supporting washout: a 2025 retrospective study (Kushner et al., Obesity Science & Practice) found no difference in final weight-loss outcomes between washout and overlap strategies, but washout patients reported 18% lower nausea rates during the first month of tirzepatide
Adv Diab Metab
Conclusion In summary, to the best knowledge, the present study is the first to demonstrated that intravenous L-carnitine administration boosted the effects of modified fasting therapy on weight loss and alleviated metabolic abnormalities
Results also revealed that this amino acid can prevent exercise-induced muscle damage based on the reduced efflux of inflammatory enzymes and reduced oxidative stress during exercise
Jeonghan Kim, R
Clinicians working with patients with mycotoxin exposure and/or symptoms may consider working with the following: Foundational support Multivitamin/mineral, probiotic (acidophilus + bifidus strains), antioxidants, and essential fatty acids Detoxification support NAC, glutathione Binders Anti-fungals These pharmaceuticals should be assessed for use on a clinical case-by-case basis ONLY given challenges related to their potential, significant side-effects
